“I buy on the assumption that they could close the market the next day and not reopen it for five years.”
— Warren Buffett
A five-year holding period can be a useful test of how a stock performs through changing market conditions, especially when dividends are reinvested. For Marsh & McLennan Companies Inc (NYSE: MRSH), a $10,000 investment made on 09/09/2021 and held through 09/08/2026 grew to $12,172.38 on a total return basis. That translates to a 21.71% cumulative return, or 4.01% annualized, with dividend reinvestment included.
MRSH 5-Year Return Summary
| Start date: | 09/09/2021 |
|
|||
| End date: | 09/08/2026 | ||||
| Start price/share: | $160.29 | ||||
| End price/share: | $180.52 | ||||
| Starting shares: | 62.39 | ||||
| Ending shares: | 67.42 | ||||
| Dividends reinvested/share: | $14.65 | ||||
| Total return: | 21.71% | ||||
| Average annual return: | 4.01% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $12,172.38 | ||||
The result is straightforward: over this five-year period, Marsh & McLennan produced a positive total return, but most of the gain did not come from sharp share-price appreciation alone. The stock rose from $160.29 to $180.52, while reinvested dividends increased the share count from 62.39 to 67.42. That combination lifted the ending value above what price appreciation by itself would have produced.
[These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
What Drove the Total Return
MRSH’s five-year return reflects two distinct components:
- Capital appreciation: the share price increased by $20.23, from $160.29 to $180.52.
- Dividend income: Marsh & McLennan paid $14.65 per share over the period, and reinvesting those payments added to the ending share count.
This distinction matters because total return can differ materially from price return. In slower-growth, dividend-paying stocks, reinvested income can account for a meaningful share of long-term compounding. Here, the stock’s cash distributions helped convert a modest price gain into a stronger all-in investment result.
Dividend Yield and Yield on Cost
Based on the most recent annualized dividend rate of $3.96 per share, MRSH has a current yield of approximately 2.19% using the ending share price of $180.52. Another useful measure is yield on cost, which compares the current annualized dividend with the original purchase price. On that basis, the $3.96 dividend against the initial $160.29 share price implies a yield on cost of about 2.47%.
Yield on cost does not measure the return available to a new buyer today, but it does show how a growing dividend stream can improve the income profile of a long-held position. For income-oriented equity strategies, that can be an important part of the investment case over time.
Why Marsh & McLennan Often Behaves Like a Compounding Business
Marsh & McLennan is best known as a professional services firm with major operations in insurance brokerage, risk advisory, reinsurance, consulting, and human capital advisory. Businesses with recurring client relationships, service-based revenue, and disciplined capital allocation often generate steadier cash flows than more cyclical industries. That profile can support regular dividend payments and incremental long-term compounding, even when near-term share-price gains are not dramatic.
That said, a stable operating profile does not guarantee outsized equity returns over every five-year window. Entry valuation, earnings growth, acquisitions, interest-rate conditions, and the broader equity multiple assigned to defensive service companies all influence realized shareholder returns.
Key Takeaways
- A $10,000 investment in MRSH on 09/09/2021 grew to $12,172.38 by 09/08/2026.
- The five-year total return was 21.71% with dividends reinvested.
- The annualized return was 4.01%.
- Dividends played an important role, adding both cash income and additional shares through reinvestment.
- At the ending share price, the annualized dividend yield was approximately 2.19%.
For long-term holders, the main lesson from this MRSH investment result is that patient returns often come from a combination of moderate price appreciation and reliable dividend compounding rather than from any single driver alone.
More investment wisdom to ponder:
“Most investors want to do today what they should have done yesterday.” — Larry Summers
